Colin Kealey on the non-pharmaceutical adolescent ADHD treatment with NeuroSIgma - podcast episode cover

Colin Kealey on the non-pharmaceutical adolescent ADHD treatment with NeuroSIgma

Feb 13, 202339 min
--:--
--:--
Listen in podcast apps:
Metacast
Spotify
Youtube
RSS

Episode description

Colin Kealey is the President and CEO of NeuroSigma which is commercializing the Monarch eTNS System, the first non-drug treatment for pediatric ADHD cleared by the FDA. 

Top 3 Takeaways:

  • NeuroSigma is commercializing the Monarch eTNS system, a wearable medical device that stimulates the trigeminal nerve on the forehead, as a treatment for neurologic and neuropsychiatric indications.
  • The Monarch eTNS System is FDA cleared as a treatment for pediatric ADHD, ages 7 – 12. Clinical trials in this population show a response rate of 50% with a only mild side effects observed in clinical trials to date.
  • NeuroSigma is also developing its eTNS technology for other indications including epilepsy and depression and is currently running two large double-blind randomized controlled trials in ADHD to expand the label into adolescents, and for using the device as adjunctive therapy.
  •  

0:45 "Do you want to introduce yourself better than I just did?"

 7:15 What is the efficacy of your device?

8:45 "What are some typical side effects of pharmaceutical ADHD treatments and what are some typical side effects of your guys' treatment?"

16:45 That was the pharmaceutical side effects, how about the neurostimulator side effects?

20:00 How does it work sleeping with a wired system?

21:45 "Were you guys able to cross-reference with any other sleep metrics to see if the quality of sleep diminished or maybe even increased?"

24:30 What's the protocol for using this device?

26:30 Could adults use this also?

28:30 Will college students use this as a study aid?

29:30 "What does your funding look like?"

35:15 How will you prevent Chinese knockoffs?

38:30 " Is there anything that we didn't talk about that you wanted to mention?"

 

For the best experience, listen in Metacast app for iOS or Android
Open in Metacast
Colin Kealey on the non-pharmaceutical adolescent ADHD treatment with NeuroSIgma | Neural Implant podcast - the people behind Brain-Machine Interface revolutions - Listen or read transcript on Metacast